Liu Z - Search Results

1

A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients.

Yuan J, Liu Z, Wu Z, Yan L, Yang J, Shi Y. Yuan J, et al. Among authors: liu z. Front Immunol. 2022 Oct 7;13:990571. doi: 10.3389/fimmu.2022.990571. eCollection 2022. Front Immunol. 2022. PMID: 36275751 Free PMC article.

2

Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.

Zhang P, Liu Z, Wang D, Li Y, Xing Y, Xiao Y. Zhang P, et al. Among authors: liu z. Front Immunol. 2021 Aug 26;12:724541. doi: 10.3389/fimmu.2021.724541. eCollection 2021. Front Immunol. 2021. PMID: 34512654 Free PMC article.

3

m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.

Liu Z, He J, Han J, Yang J, Liao W, Chen N. Liu Z, et al. Front Immunol. 2022 Jan 7;12:762243. doi: 10.3389/fimmu.2021.762243. eCollection 2021. Front Immunol. 2022. PMID: 35069534 Free PMC article.

4

Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma.

Liu Z, He J, Hu X. Liu Z, et al. Front Genet. 2022 Sep 2;13:975190. doi: 10.3389/fgene.2022.975190. eCollection 2022. Front Genet. 2022. PMID: 36118882 Free PMC article.

5

Comprehensive Molecular Analysis Identified an SRSF Family-Based Score for Prognosis and Therapy Efficiency Prediction in Hepatocellular Carcinoma.

Yuan J, Liu Z, Wu Z, Yang J, Lv T. Yuan J, et al. Among authors: liu z. Cancers (Basel). 2022 Sep 28;14(19):4727. doi: 10.3390/cancers14194727. Cancers (Basel). 2022. PMID: 36230650 Free PMC article.

6

Construction and validation of an IRF4 risk score to predict prognosis and response to immunotherapy in hepatocellular carcinoma.

Yuan J, Liu Z, Wu Z, Yang J, Yang J. Yuan J, et al. Among authors: liu z. Int Immunopharmacol. 2022 Dec;113(Pt A):109411. doi: 10.1016/j.intimp.2022.109411. Epub 2022 Nov 8. Int Immunopharmacol. 2022. PMID: 36461603 Free article.

7

Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation.

Liu Z, Zhu F, Zhang P, Qian B, Liu W, Xiao Y, Chen N, He Q, Xiao J. Liu Z, et al. Among authors: liu w. Front Genet. 2022 Nov 23;13:1074981. doi: 10.3389/fgene.2022.1074981. eCollection 2022. Front Genet. 2022. PMID: 36506302 Free PMC article.

8

Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma.

Jiang C, Liu Z, Yuan J, Wu Z, Kong L, Yang J, Lv T. Jiang C, et al. Among authors: liu z. Int J Mol Sci. 2023 Feb 22;24(5):4335. doi: 10.3390/ijms24054335. Int J Mol Sci. 2023. PMID: 36901767 Free PMC article.

9

UBAP2 contributes to radioresistance by enhancing homologous recombination through SLC27A5 ubiquitination in hepatocellular carcinoma.

Liu Z, Yuan J, Zeng Q, Wu Z, Han J. Liu Z, et al. Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167481. doi: 10.1016/j.bbadis.2024.167481. Epub 2024 Aug 24. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 39186963

10

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.

Liu Z, Mi M, Li X, Zheng X, Wu G, Zhang L. Liu Z, et al. J Cell Mol Med. 2020 Nov;24(21):12444-12456. doi: 10.1111/jcmm.15762. Epub 2020 Sep 23. J Cell Mol Med. 2020. PMID: 32967061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,416 results

Search Page

Filters